• Link to Facebook
  • Link to Instagram
  • Link to X
  • Home
  • Members
  • En Español
  • Contact
National Cancer Institute Clinical Oncology Research Program
SCOR - Southeast Clinical Oncology Research Consortium
  • Clinical Trials
  • Find a Doctor
  • About SCOR
    • Become a Member
  • Resources
    • Videos
    • Articles
    • Community Members
    • Community Support Groups
    • FAQs
    • Patient Resources
  • Menu Menu
  • Home
  • Members
  • En Español
  • Clinical Trials
  • Find a Clinical Trial Doctor
  • About SCOR
    • About SCOR
    • Become a Member of SCOR
  • Resources
    • Videos
    • News
    • Community Members
    • Community Support Groups
    • Clinical Trials FAQ
    • Clinical Trial Patient Resources
  • Contact SCOR
  • Privacy Policy
  • Site Map

Multiple Myeloma Clinical Trial Benefits

March 11, 2020/in Cancer, Cancer Clinical Trial, Clinical Trial, Clinical Trial Success, NIH

Multiple Myeloma is a type of blood cancer that starts in white blood cells called plasma cells, which help your body fight infections. Mutations occur when the genetic material in plasma cells changes, causing plasma cells to become problematic myeloma cells. As myeloma cells multiply, they crowd out normal blood cells inside bone marrow, and that’s when symptoms can appear.

In this video from the National Institutes of Health (NIH), Pamela shares her reasons for choosing to participate in a clinical trial to help treat her stage 3B multiple myeloma.  Find more information about clinical trials in your community here.

Sources: www.nih.gov, www.multiplemyelomaandyou.com

Share this entry
  • Share on Facebook
  • Share on X
  • Share on Pinterest
  • Share on LinkedIn
  • Share by Mail
https://southeastclinicaloncology.org/wp-content/uploads/2018/06/SCOR-Southeast-Clinical-Oncology-Research_Logo.png 0 0 BCeditor https://southeastclinicaloncology.org/wp-content/uploads/2018/06/SCOR-Southeast-Clinical-Oncology-Research_Logo.png BCeditor2020-03-11 12:28:202020-03-11 12:28:20Multiple Myeloma Clinical Trial Benefits
You might also like
Olivera Finn immunologist cancer vaccine Why You Shouldn’t Fear Clinical Trials when Faced with Cancer
Olivera Finn immunologist cancer vaccine Stage IV Survivor’s Ongoing Clinical Trial Success
Cancer drug research Drug Discovery and Development
Olivera Finn immunologist cancer vaccine May is Skin Cancer Awareness Month
Olivera Finn immunologist cancer vaccine
Olivera Finn immunologist cancer vaccine What is SCOR?
Olivera Finn immunologist cancer vaccine Pursuing a Cancer Prevention Vaccine
Olivera Finn immunologist cancer vaccine Clinical Trials: Tomorrow’s Treatment Today

A program of the National Cancer Institute of the National Institutes of Health

Community Resources

FAQ's

Participating SCOR Members

  • Cary, NC
  • Charleston, SC
  • Charlotte, NC
  • Chesapeake, VA
  • Florence, SC
  • Fort Myers, FL
  • Gastonia, NC
  • Goldsboro, NC
  • Greensboro, NC
  • Hendersonville, NC – Pardee
  • Hendersonville, NC – Advent Health
  • Kingsport, TN
  • Martinsville, VA
  • New Bern, NC
  • Pinehurst, NC
  • Richmond, VA
  • Rocky Mount, NC
  • Savannah, GA
  • Wilmington, NC
  • Winston Salem, NC

Contact SCOR

Southeast Clinical Oncology
Research Consortium

2150 Country Club Road,
Suite 200
Winston Salem, NC 27104
T: (336) 448-1417
F: (336) 448-1425

Member Communities

Cary, NC
Charleston, SC
Charlotte, NC
Chesapeake, VA
Florence, SC
Fort Myers, FL
Gastonia, NC
Goldsboro, NC
Greensboro, NC
Hendersonville, NC – Pardee
Hendersonville, NC – AdventHealth
Kingsport, TN
Martinsville, VA
New Bern, NC
Pinehurst, NC
Richmond, VA
Rocky Mount, NC
Savannah, GA
Syracuse, NY
Wilmington, NC
Winston-Salem, NC

National Cancer Institute Clinical Oncology Research Program, Grant #5UG1CA-189858. All content © Southeast Clinical Oncology Research Consortium. All rights reserved. 2150 Country Club Road, Suite 200, Winston-Salem, NC 27104-4241 | Phone: (336) 448-1417 | Fax: (336) 448-1425 | Site Map | Privacy Policy | Website Design by Built Creative.
  • Link to Facebook
  • Link to Instagram
  • Link to X
Link to: Sanford’s Cook is the First to Undergo Procedure to “Zap” Lung Cancer Link to: Sanford’s Cook is the First to Undergo Procedure to “Zap” Lung Cancer Sanford’s Cook is the First to Undergo Procedure to “Zap”... Link to: Why are a lower percentage of cancer patients dying? Link to: Why are a lower percentage of cancer patients dying? Why are a lower percentage of cancer patients dying?
Scroll to top Scroll to top Scroll to top